Literature DB >> 22575979

Surgical treatment and prognosis of octogenarians with non-small cell lung cancer.

Jing Zhang1, Zhi-Qiang Xue, Xiang-Yang Chu, Yun-Xi Wang, Jia-Hua Zhao, Chi Xu, Li-Guo Yin.   

Abstract

OBJECTIVE: To explore the clinical characteristics, surgical treatment and prognosis of non-small cell lung cancer (NSCLC) among elderly patients over 80 years.
METHODS: The clinical data, surgical methods, perioperative management, postoperative complications and prognosis of 52 NSCLC patients aged over 80 years were retrospectively analyzed.
RESULTS: Out of 52 cases, 27 had a long-term smoking history (51.9%) and 44 were with other diseases (84.6%). Lobectomy was done in 32 cases (65.4%), sub-lobectomy in 20 cases (38.5%), including pulmonary wedge resection in 16 cases (30.8%) and lung segment resection in 4 cases (7.7%). The postoperative complication rate was 44.2% (23/52); the complication rate after lobectomy was 62.5% (20/32) and that after sub-lobectomy was 25% (5/20), with significant difference between lobectomy and sub-lobectomy (P<0.05). Postoperative mortality was 3.8% (2/52). Pathological TNM staging: I a 27 cases (51.9%), I b 12 cases (23.1%), II a 8 cases (15.4%), II b 3 cases (5.8%) and III a 2 cases (3.8%). The 1-, 3- and 5-year survival rate after operation was 87.1%, 59.8%, 19.1%. The 1-, 3- and 5-year survival rate was 86.0%, 61.8%, 21.5% in the patients after lobectomy; that was 89.0%, 58.3%, 18.7% in the patients after sub-lobectomy, with no significant difference between two surgical methods (P>0.05).
CONCLUSIONS: Octogenarians with NSCLC are often afflicted with comorbidity, so perioperative management is more complex. Strictly adhering to indications, surgery is still an important treatment of NSCLC patients over 80.
Copyright © 2012 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22575979     DOI: 10.1016/S1995-7645(12)60079-0

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  3 in total

1.  Prognostic factors for surgically managed patients with stage II non-small cell lung cancer.

Authors:  Liming Wang; Yang Liu; Shun Xu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 2.  [Progress of Sublobectomy for the Treatment of Stage I Non-small Cell Lung Cancer in the Elderly].

Authors:  Siyuan Dong; Lin Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-10-20

Review 3.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors.

Authors:  Brett C Bade; Justin D Blasberg; Vincent J Mase; Ulas Kumbasar; Andrew X Li; Henry S Park; Roy H Decker; David C Madoff; Whitney S Brandt; Gavitt A Woodard; Frank C Detterbeck
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.